 | Up a level |
Boell, B., Buchheidt, D., Hasenkamp, J., Kiehl, M., Kiderlen, T., Kochanek, M., Koldehoff, M., Kostrewa, P., Loehnert, A., Mellinghoff, S. C., Metzner, B., Penack, O., Ruhnke, M., Enrico, S., Vehreschild, M., Weissinger, F., Wolf, H. -H, Hentrich, M. and Karthaus, M. (2018). New AGIHO-guideline for diagnosis and therapy of CVC-associated infections. Oncol. Res. Treat., 41. S. 147 - 148. BASEL: KARGER. ISSN 2296-5262
Frontzek, F., Ziepert, M., Nickelsen, M., Altmann, B., Glass, B., Haenel, M., Truemper, L., Held, G., Bentz, M., Borchmann, P., Dreyling, M., Viardot, A., Kroschinsky, F., Metzner, B., Staiger, A. M., Horn, H., Ott, G., Rosenwald, A., Loeffler, M., Lenz, G. and Schmitz, N. (2020). 10-year follow-up of the R-MegaCHOEP trial: conditional survival analysis reveals 1-year progression-free survival as crucial prognostic factor for long-term outcome in young high-risk patients with aggressive B-cell lymphoma. Oncol. Res. Treat., 43 (SUPPL 4). S. 64 - 65. BASEL: KARGER. ISSN 2296-5262
Glass, B., Ziepert, M., Reiser, M., Freund, M., Truemper, L., Metzner, B., Feller, A., Loeffler, M., Pfreundschuh, M. and Schmitz, N. (2010). High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann. Oncol., 21 (11). S. 2255 - 2262. OXFORD: OXFORD UNIV PRESS. ISSN 0923-7534
Koenigsmann, M., Casper, J., Kahl, C., Basara, N., Sayer, H. G., Behre, G., Theurich, S., Christopeit, M., Mohren, M., Reichle, A., Metzner, B., Ganser, A., Stadler, M., Uharek, L., Balleisen, L., Hinke, A., Hinke, R. and Niederwieser, D. (2014). Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone Marrow Transplant., 49 (3). S. 410 - 416. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Murawski, N., Poeschel, V., Ziepert, M., Altmann, B., Dreyling, M., Borchmann, P., Viardot, A., Luminari, S., Witzens-Harig, M., Dierlamm, J., Haenel, M., Truemper, L., Metzner, B., Lengfelder, E., Keller, U., Ruebe, C., Berdel, C., Schmitz, N., Held, G. and Pfreundschuh, M. (2018). Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA. Oncol. Res. Treat., 41. S. 238 - 239. BASEL: KARGER. ISSN 2296-5262
Wilhelm, M., Smetak, M., Reimer, P., Geissinger, E., Ruediger, T., Metzner, B., Schmitz, N., Engert, A., Schaefer-Eckart, K. and Birkmann, J. (2016). First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer J., 6. LONDON: NATURE PUBLISHING GROUP. ISSN 2044-5385